Inhibition of the Staphylococcus aureus NADPH-dependent enoyl-acyl carrier protein reductase by triclosan and hexachlorophene
about
Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs1,2-dithiole-3-ones as potent inhibitors of the bacterial 3-ketoacyl acyl carrier protein synthase III (FabH)Relationship between triclosan and susceptibilities of bacteria isolated from hands in the communityExposure of sink drain microcosms to triclosan: population dynamics and antimicrobial susceptibilityStructural elucidation of the specificity of the antibacterial agent triclosan for malarial enoyl acyl carrier protein reductaseCrystal structure of enoyl-acyl carrier protein reductase (FabK) fromStreptococcus pneumoniaereveals the binding mode of an inhibitorSlow-Onset Inhibition of the FabI Enoyl Reductase from Francisella tularensis : Residence Time and in Vivo ActivityStructure and nucleotide specificity of Staphylococcus aureus dihydrodipicolinate reductase (DapB)Rational Optimization of Drug-Target Residence Time: Insights from Inhibitor Binding to the Staphylococcus aureus FabI Enzyme–Product ComplexStaphylococcus aureus FabI: Inhibition, Substrate Recognition, and Potential Implications for In Vivo EssentialityRational Design of Broad Spectrum Antibacterial Activity Based on a Clinically Relevant Enoyl-Acyl Carrier Protein (ACP) Reductase InhibitorBiochemical and structural characterization of the apicoplast dihydrolipoamide dehydrogenase of Plasmodium falciparumUse of germicides in the home and the healthcare setting: is there a relationship between germicide use and antibiotic resistance?Dual-resolution molecular dynamics simulation of antimicrobials in biomembranesHexachlorophene is a potent KCNQ1/KCNE1 potassium channel activator which rescues LQTs mutantsMechanism and inhibition of saFabI, the enoyl reductase from Staphylococcus aureusThe enoyl-[acyl-carrier-protein] reductases FabI and FabL from Bacillus subtilisThe MexJK efflux pump of Pseudomonas aeruginosa requires OprM for antibiotic efflux but not for efflux of triclosan3-oxoacyl-ACP reductase from Schistosoma japonicum: integrated in silico-in vitro strategy for discovering antischistosomal lead compoundsCommunity-level assessment of dental plaque bacteria susceptibility to triclosan over 19 yearsCross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ.Response of Bacillus subtilis to cerulenin and acquisition of resistance.High-frequency transposition for determining antibacterial mode of action.Defining and combating the mechanisms of triclosan resistance in clinical isolates of Staphylococcus aureus.Mutational analysis of the triclosan-binding region of enoyl-ACP (acyl-carrier protein) reductase from Plasmodium falciparum.Mechanisms of bacterial biocide and antibiotic resistance.Biofilms in vitro and in vivo: do singular mechanisms imply cross-resistance?Staphylococcus epidermidis isolated in 1965 are more susceptible to triclosan than current isolates.Staphylococcus aureus but not Listeria monocytogenes adapt to triclosan and adaptation correlates with increased fabI expression and agr deficiencyGuideline for Hand Hygiene in Health-Care Settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force.Mechanism of action of NB2001 and NB2030, novel antibacterial agents activated by beta-lactamases.Mutations upstream of fabI in triclosan resistant Staphylococcus aureus strains are associated with elevated fabI gene expression.Fatty acid biosynthesis as a target for novel antibacterials'FAS't inhibition of malaria.Expression, purification and characterization of enoyl-ACP reductase II, FabK, from Porphyromonas gingivalis.Identification and characterization of TriABC-OpmH, a triclosan efflux pump of Pseudomonas aeruginosa requiring two membrane fusion proteinsHow to select the right mouthrinses in periodontal prevention and therapy. Part II. Clinical use and recommendations.Prediction of mechanisms of action of antibacterial compounds by gene expression profiling.Plasmid selection in Escherichia coli using an endogenous essential gene marker.Effects of triclosan-containing rinse on the dynamics and antimicrobial susceptibility of in vitro plaque ecosystems.
P2860
Q24562996-D3372C74-2524-4C2E-86C6-EF996FE054C8Q24564306-1533EAFC-4972-409D-8068-B00C1D0AECB1Q24564324-9D8BA968-D4D5-49E0-9D61-1644721A1F4CQ24678992-DFF2F8A5-08A7-4CE4-AB5C-9E7E881D7695Q27637344-D81EB410-B52B-47E0-B174-A325EB88D280Q27649956-B42CD703-D9A0-4ADC-BD30-825FD2ABAA6BQ27653711-68D5178D-B6E8-4F4D-8BC6-10CF5C3A7B77Q27671283-EF49E8CE-24CE-4704-A963-202AEDB5BDABQ27678258-D34C43FE-7643-415E-918D-64FF10E90D4DQ27679034-1A2C8BB0-54BF-417A-9A70-E2062EDAEC37Q27683440-BAACB509-13AF-491F-AD7A-F727E450BD69Q27973614-919CCEDC-FBC6-4EA8-A8E5-E0B82135E30CQ28265803-B14DD95F-BC34-4DD3-A265-628A25FA7490Q28299896-D1F0FC6D-63F3-45BF-A74B-4785C166CF98Q28484309-BAE05624-F2BC-40B5-AEC6-EFEB773A7D76Q28485592-509EE867-0EB2-4959-9B3A-2139AE11E07DQ28488911-518046C5-CEB9-43F5-997B-983F9A2850F2Q28492850-B3721513-39DC-4782-879C-0DFAF2ED131BQ28533754-7FED30D9-B7BB-4996-8186-78F60AF6D9EAQ33824705-7A331D15-A7F3-46A1-A3F3-88F0F056388DQ33981336-05FD4B21-BB6B-4DB0-8423-C3C233760464Q33996150-2ABF3334-7C21-45D2-A9BD-238CC22E0942Q34011008-A0D51489-8D32-40B3-98B1-55491E7E36B1Q34142386-AFE2B1C3-257D-4CCF-9458-31809F5A53B9Q34320334-DC2C1046-97A0-4232-8252-4FDA3C9DA11EQ34631438-E6CF3D24-E352-4768-8E48-9165F086EAB2Q34631472-DB77CED5-641E-435B-8A35-05F028CFCB96Q34685701-0101120A-2EE9-4197-A8DE-3FA667C76466Q34880970-6D6F9503-C847-4DE8-B123-1E202B04449FQ35039821-A69D048B-C0EC-4551-A388-4459B80323D7Q35547321-B9810AA4-5B3E-4647-A359-1D0C9F76913EQ35618052-40C71A2D-098D-4FB4-99C9-82630D05DD7EQ35713880-9FE0E0A0-8218-44E1-8B54-6C7B893BD673Q35865145-BD1873C2-B694-4C0C-BEB6-07B292BE04E9Q36203279-1ED6A744-79FB-40D1-AB12-2F335BBEF4DAQ36314900-76951F6F-0266-4937-8960-D1414D0012FAQ36383971-48AD42D7-A945-489A-B5B4-837096555C13Q36670294-E0BFEA10-4219-4587-9BB9-5F238EFE36F5Q36856568-093D8E07-1A5E-4AFE-9081-90BD5EE30062Q36880926-170677DE-9286-4FF2-BFA2-D276C599DE67
P2860
Inhibition of the Staphylococcus aureus NADPH-dependent enoyl-acyl carrier protein reductase by triclosan and hexachlorophene
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Inhibition of the Staphylococc ...... triclosan and hexachlorophene
@ast
Inhibition of the Staphylococc ...... triclosan and hexachlorophene
@en
Inhibition of the Staphylococc ...... triclosan and hexachlorophene
@nl
type
label
Inhibition of the Staphylococc ...... triclosan and hexachlorophene
@ast
Inhibition of the Staphylococc ...... triclosan and hexachlorophene
@en
Inhibition of the Staphylococc ...... triclosan and hexachlorophene
@nl
prefLabel
Inhibition of the Staphylococc ...... triclosan and hexachlorophene
@ast
Inhibition of the Staphylococc ...... triclosan and hexachlorophene
@en
Inhibition of the Staphylococc ...... triclosan and hexachlorophene
@nl
P2093
P2860
P3181
P356
P1476
Inhibition of the Staphylococc ...... triclosan and hexachlorophene
@en
P2093
P2860
P304
P3181
P356
10.1074/JBC.275.7.4654
P407
P577
2000-02-18T00:00:00Z